3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Pain
1
Constipation
1
Interventions
tegaserod
3
naloxegol
2
oxycodone naloxone combination
1
alvimopan
1
Sennosides
1
Phenolphthalein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Constipation
×
oxycodone naloxone combination
×
Clear all
NCT01014559
2015-09-28
OXN3505
Mundipharma SAS
Phase 3
Terminated
225 enrolled